Exposure Therapy For Veterans With PTSD And Panic Attacks
This trial is active, not recruiting.
|Conditions||ptsd, panic attacks|
|Treatments||multiple channel exposure therapy-veterans, cognitive-processing therapy|
|Sponsor||VA Office of Research and Development|
|Start date||January 2013|
|End date||September 2016|
|Trial size||62 participants|
|Trial identifier||NCT01033136, CDA2-012-09F|
To evaluate the feasibility, acceptability and effectiveness of Multiple Channel Exposure Therapy-Veterans (MCET-V) as a treatment for returning service members with comorbid PTSD and panic disorder in two phases. The second phase of the study will examine the effectiveness of MCET-V by comparing it to Cognitive Processing Therapy, a standard PTSD treatment.
|Endpoint classification||efficacy study|
|Intervention model||single group assignment|
time frame: 1-week post-treatment and 3-month follow-up
time frame: Baseline and 3-month follow-up
Male or female participants from 18 years up to 75 years old.
Inclusion Criteria: - being a Veteran of any era; - being enrolled in the TRP at the MEDVAMC, with a current diagnosis of PTSD and PD; - being stable on psychotropic medication for 4 weeks before study participation; and - being at least 18 years of age. Exclusion Criteria: - active substance dependence, or bipolar or psychotic disorders; - severe depression and [active suicidal ideation and intent] (based on ADIS-IV & BDI-II); - cognitive impairment as indicated by the SLUMS; and - Veterans currently receiving psychosocial treatment specifically targeting PTSD or panic symptoms.
|Official title||Exposure Therapy for Veterans With PTSD and Panic Attacks|
|Principal investigator||Ellen Teng, PhD|
|Description||With the increasing number of Operations Iraqi Freedom and Enduring Freedom (OIF/OEF) Veterans returning from war-zone areas, many will experience anxiety disorders such as PTSD and comorbid problems. Currently, about one in every six OIF/OEF Veterans experiences PTSD and co-occurring PD. Although effective treatments exist for treating one or the other, we do not yet have treatments that can simultaneously target PTSD and PD. Thus, recent attention has focused on the development of multi-component treatments that simultaneously address PTSD and PD. This study is the first systematic investigation of a time-limited, multi-component cognitive-behavioral treatment for Veterans with specific comorbid anxiety problems. The purpose of the second phase of the study is to evaluate the effectiveness of the multi-component cognitive-behavioral treatment in comparison to standard PTSD treatment in military personnel returning from active duty.|
Call for more information